12345...102030...

DC Comics March 2015 Covers and Solicitations

Home Mail Search News Sports Finance Weather Games Answers Screen Flickr Mobile More Celebrity Movies Music TV Groups Health Style Beauty Food Parenting DIY Tech Shopping Travel Autos Homes Upgrade to the new Firefox Sign In Mail Help Account Info Help Suggestions



Sources Are Here

(1) DC Comics March 2015 Covers and Solicitations
URL: http://news.yahoo.com/dc-comics-march-2015-covers-220000474.html;_ylt=AwrBJR.sxo9U2V4AMSj_wgt.


ASTRO recognized with distinguished 'Accreditation with Commendation' status from ACCME

PUBLIC RELEASE DATE: 12-Dec-2014 Contact: Michelle Kirkwood michellek@astro.org 703-286-1600 American Society for Radiation Oncology @ASTRO_org Fairfax, Va., December 12, 2014–The American Society for Radiation Oncology’s (ASTRO’s) education credentials have been recognized and upgraded by the Accreditation Council for Continuing Medical Education (ACCME) from Accreditation to Accreditation with Commendation, approved at the ACCME’s December 2014 meeting. ASTRO’s Accreditation status was renewed on March 31, 2014, for four years and has now been extended for two additional years as Accreditation with Commendation until March 31, 2020.



Sources Are Here

(1) ASTRO recognized with distinguished 'Accreditation with Commendation' status from ACCME
URL: http://ri.search.yahoo.com/_ylt=AwrBEiT7xItU7TMAWYv_wgt./RV=2/RE=1418474876/RO=10/RU=http://www.eurekalert.org/pub_releases/2014-12/asfr-arw121214.php/RK=0/RS=JN6Xf2cbWiiwquiEIpHAZO8mFJ0-


ASTRO Recognized with Distinguished "Accreditation with Commendation" Status From the Accreditation Council for …

Contact Information Available for logged-in reporters only Newswise Fairfax, Va., December 12, 2014The American Society for Radiation Oncologys (ASTROs) education credentials have been recognized and upgraded by the Accreditation Council for Continuing Medical Education (ACCME) from Accreditation to Accreditation with Commendation, approved at the ACCMEs December 2014 meeting. ASTROs Accreditation status was renewed on March 31, 2014, for four years and has now been extended for two additional years as Accreditation with Commendation until March 31, 2020. The ACCME is the national accrediting board for all medical education organizations in the U.S.



Sources Are Here

(1) ASTRO Recognized with Distinguished "Accreditation with Commendation" Status From the Accreditation Council for ...
URL: http://ri.search.yahoo.com/_ylt=AwrBEiT7xItU7TMAWov_wgt./RV=2/RE=1418474876/RO=10/RU=http://www.newswise.com/articles/view/627391/?sc=rsmn/RK=0/RS=_ZrzUpjIOFOirBGPpv7HG8ncxMw-


Analysis Shows Increased Use of Hypofractionated Whole-Breast Irradiation for Patients with Early-Stage Breast Cancer

Contact Information Available for logged-in reporters only Newswise Fairfax, Va., December 9, 2014The use of hypofractionated whole-breast irradiation (HF-WBI) for patients with early-stage breast cancer increased 17.4 percent from 2004 to 2011, and patients are more likely to receive HF-WBI compared to conventionally fractionated whole-breast irradiation (CF-WBI) when they are treated at an academic center or live 50 miles away from a cancer center, according to a study published in the December 1, 2014 issue of the International Journal of Radiation Oncology Biology Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology (ASTRO). An analysis of randomized trials[1] demonstrated that patients with early-stage breast cancer who are treated with breast-conserving surgery and adjuvant whole-breast irradiation have improved survival and a lower risk of tumor recurrence compared to patients who are not treated with radiation therapy. Patients are commonly treated with CF-WBI; however, several recent randomized trials[2-5] have confirmed that patients treated with HF-WBI have similar disease-free and overall survival rates as those treated with CF-WBI



Sources Are Here

(1) Analysis Shows Increased Use of Hypofractionated Whole-Breast Irradiation for Patients with Early-Stage Breast Cancer
URL: http://ri.search.yahoo.com/_ylt=AwrBEiQd.YdUnlgAD6D_wgt./RV=2/RE=1418226077/RO=10/RU=http://www.newswise.com/articles/view/627218/?sc=rsmn/RK=0/RS=Zs63tqEEWLDuz6Aq8s_tJBg_k68-


Analysis shows increased use of HF-WBI for patients with early-stage breast cancer

PUBLIC RELEASE DATE: 9-Dec-2014 Contact: Michelle Kirkwood press@astro.org 703-286-1600 American Society for Radiation Oncology @ASTRO_org Fairfax, Va., December 9, 2014–The use of hypofractionated whole-breast irradiation (HF-WBI) for patients with early-stage breast cancer increased 17.4 percent from 2004 to 2011, and patients are more likely to receive HF-WBI compared to conventionally fractionated whole-breast irradiation (CF-WBI) when they are treated at an academic center or live 50 miles away from a cancer center, according to a study published in the December 1, 2014 issue of the International Journal of Radiation Oncology Biology Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology (ASTRO). An analysis of randomized trials[1] demonstrated that patients with early-stage breast cancer who are treated with breast-conserving surgery and adjuvant whole-breast irradiation have improved survival and a lower risk of tumor recurrence compared to patients who are not treated with radiation therapy



Sources Are Here

(1) Analysis shows increased use of HF-WBI for patients with early-stage breast cancer
URL: http://ri.search.yahoo.com/_ylt=AwrBEiQd.YdUnlgAEKD_wgt./RV=2/RE=1418226077/RO=10/RU=http://www.eurekalert.org/pub_releases/2014-12/asfr-asi120914.php/RK=0/RS=x_PuGMvDUZhfD2oN2r2dES4BMKw-


Increased use of hypofractionated whole-breast irradiation for patients with early-stage breast cancer

The use of hypofractionated whole-breast irradiation (HF-WBI) for patients with early-stage breast cancer increased 17.4 percent from 2004 to 2011, and patients are more likely to receive HF-WBI compared to conventionally fractionated whole-breast irradiation (CF-WBI) when they are treated at an academic center or live 50 miles away from a cancer center, according to a study published in the December 1, 2014 issue of the International Journal of Radiation Oncology Biology Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology (ASTRO). An analysis of randomized trials demonstrated that patients with early-stage breast cancer who are treated with breast-conserving surgery and adjuvant whole-breast irradiation have improved survival and a lower risk of tumor recurrence compared to patients who are not treated with radiation therapy. Patients are commonly treated with CF-WBI; however, several recent randomized trials[2-5] have confirmed that patients treated with HF-WBI have similar disease-free and overall survival rates as those treated with CF-WBI



Sources Are Here

(1) Increased use of hypofractionated whole-breast irradiation for patients with early-stage breast cancer
URL: http://ri.search.yahoo.com/_ylt=AwrBEiQd.YdUnlgAEaD_wgt./RV=2/RE=1418226077/RO=10/RU=http://www.sciencedaily.com/releases/2014/12/141209115809.htm/RK=0/RS=D4jUA_gSlzvv75a0vdC9mqFDtTM-


ASTRO Receives Three MarCom Awards

Contact Information Available for logged-in reporters only Newswise Fairfax, Va., December 5, 2014The American Society for Radiation Oncology (ASTRO) received three 2014 MarCom Awards. MarCom Awards were presented to ASTRO for the Summer 2014 issue of ASTROnews, the RO-ILS: Radiation Oncology Incident Learning SystemTM marketing campaign and the most recent edition of the Radiation Therapy for Prostate Cancer patient brochure. The MarCom Awards, administered and judged by the Association of Marketing and Communications Professionals, is an international creative competition recognizing outstanding achievement by marketing and communication professionals.



Sources Are Here

(1) ASTRO Receives Three MarCom Awards
URL: http://ri.search.yahoo.com/_ylt=AwrBEiRrzINUu3QALkn_wgt./RV=2/RE=1417952491/RO=10/RU=http://www.newswise.com/articles/view/627082/?sc=rsmn/RK=0/RS=fG5LO4YTfGvSNZJmnyg1AeTqE_Y-


Breakthrough in astroparticle physics

03.12.2014 – (idw) Julius-Maximilians-Universitt Wrzburg The astrophysicists Thomas Bretz and Daniela Dorner have developed a novel camera technology which for the first time allows sources of cosmic gamma radiation to be observed without interruption even when the moon is shining brightly.



Sources Are Here

(1) Breakthrough in astroparticle physics
URL: http://ri.search.yahoo.com/_ylt=AwrBJR.ccoBUwBUA0rL_wgt./RV=2/RE=1417732892/RO=10/RU=http://www.uni-protokolle.de/nachrichten/id/289413//RK=0/RS=smyurApfEBC_QsqNFjVW4CMdbWQ-


Spotted: First quadruple star image produced by gravity

A newly discovered supernova and its four gravitationally lensed images may give researchers a way to pin down the universe's expansion rate



Sources Are Here

(1) Spotted: First quadruple star image produced by gravity
URL: http://ri.search.yahoo.com/_ylt=AwrBJR.ccoBUwBUA1LL_wgt./RV=2/RE=1417732892/RO=10/RU=http://feeds.newscientist.com/c/749/f/10897/s/41169c2f/sc/22/l/0L0Snewscientist0N0Carticle0Cdn266520Espotted0Efirst0Equadruple0Estar0Eimage0Eproduced0Eby0Egravity0Bhtml0Dcmpid0FRSS0QNSNS0Q20A120EGLOBAL0Qonline0Enews/story01.htm/RK=0/RS=P95Tsn0vRmwh7IsapoZwcZGme0k-


The Moment of Truth for BICEP2 (Synopsis) [Starts With A Bang]

Image credit: Caltech & CTCP All rights Reserved, viahttp://preposterousuniverse.com/MCTCP/astro.php. The paradigm of physicswith its interplay of data, theory and predictionis the most powerful in science. -Geoffrey West So earlier this year, the BICEP2 team shook up the world by announcing the discovery of primordial gravitational waves: a signal from the earliest stages of the Universe, going all the way back tobefore the Big Bang! Image credit:the BICEP2 collaboration, viahttp://www.cfa.harvard.edu/news/2014-05



Sources Are Here

(1) The Moment of Truth for BICEP2 (Synopsis) [Starts With A Bang]
URL: http://ri.search.yahoo.com/_ylt=AwrBJR6Vvn5Uo0MA1_T_wgt./RV=2/RE=1417621269/RO=10/RU=http://scienceblogs.com/startswithabang/2014/12/02/the-moment-of-truth-for-bicep2-synopsis//RK=0/RS=Ee9IZN4MANkautEuSfClKLgR6rw-


NVIDIA Volta, IBM POWER9 Land Contracts For New US Government Supercomputers

The launch of Oak Ridge National Laboratorys Titan Supercomputer was in many ways a turning point for NVIDIAs GPU compute business. Though already into their third generation of Tesla products by that time, getting Tesla into the worlds most powerful supercomputer is as much of a singular mark of making it as there can be.



Sources Are Here

(1) NVIDIA Volta, IBM POWER9 Land Contracts For New US Government Supercomputers
URL: http://ri.search.yahoo.com/_ylt=AwrBJSAeF2pUzSgATVb_wgt./RV=2/RE=1416267678/RO=10/RU=http://www.anandtech.com/show/8727/nvidia-ibm-supercomputers/RK=0/RS=b6s4DZWqKmNJRlKP4FMwZ49nh08-


Astronomy Update: Big Dipper star names are historical

Editors note: Astronomy Update is published on the third Saturday of the month and provided by the Chippewa Valley Astronomical Society and the L.E. Phillips Planetarium.



Sources Are Here

(1) Astronomy Update: Big Dipper star names are historical
URL: http://ri.search.yahoo.com/_ylt=AwrBEiEkRGlUeQkAUvr_wgt./RV=2/RE=1416213668/RO=10/RU=http://www.leadertelegram.com/local_news/story/article_c55e49e0-6c14-11e4-91ed-330ad13302fb.html/RK=0/RS=dFhuLKcrzfpksL3LSULdjkXMEZs-


Mounts for Astro-Imaging – Video




Mounts for Astro-Imaging In this session, owners of different mounts will go over the different aspects of the mounts they use.

Sources Are Here

(1) Mounts for Astro-Imaging - Video
URL: http://www.youtube.com/watch?v=M9yqf4tr2oE


ASTRO Commends Medicare's Decision to Cover Annual, Low-Dose CT Screening for High-Risk Lung Cancer Patients Ages 55 …

Contact Information Available for logged-in reporters only Newswise Fairfax, Va., November 14, 2014 The American Society for Radiation Oncology (ASTRO) praises the November 11, 2014, decision by the Centers for Medicare and Medicaid Services (CMS) to provide coverage for annual lung cancer screening via low-dose CT screening for those at highest-risk for lung cancer. The Proposed Decision Memo for Screening for Lung Cancer with Low Dose Computed Tomography (LDCT) (CAG-00439N) confirms that there is sufficient evidence to warrant annual lung cancer screening for patients most at-risk for developing lung cancer



Sources Are Here

(1) ASTRO Commends Medicare's Decision to Cover Annual, Low-Dose CT Screening for High-Risk Lung Cancer Patients Ages 55 ...
URL: http://ri.search.yahoo.com/_ylt=AwrBJR6JA2dUBAcA9jb_wgt./RV=2/RE=1416066057/RO=10/RU=http://www.newswise.com/articles/view/626243/?sc=rsmn/RK=0/RS=ajaL.hAl3pS_jDjUS9FhVu9inqg-


Coqui RadioPharmaceuticals Appoints Ian Turner To Board Of Directors

CORAL GABLES, Fla., Nov. 14, 2014 /PRNewswire/ — Coqui RadioPharmaceuticals Corp. , a medical isotope company working to become the first U.S



Sources Are Here

(1) Coqui RadioPharmaceuticals Appoints Ian Turner To Board Of Directors
URL: http://ri.search.yahoo.com/_ylt=AwrBJR6JA2dUBAcA_jb_wgt./RV=2/RE=1416066057/RO=10/RU=http://ca.finance.yahoo.com/news/coqui-radiopharmaceuticals-appoints-ian-turner-203000497.html/RK=0/RS=Nt9sE.RguMJss1aXC7p3tTnFe6E-



12345...102030...